Miami Cancer Institute
Locations
Transplant Summary
Overview
Miami Cancer Institute is part of the Baptist Health South Florida network, one of the largest hospital networks in South Florida. The Blood and Marrow Transplant program of Miami Cancer Institute treats hematologic malignancies in both inpatient and outpatient state of the art facilities. Our unique approach using CD34 selected products offers a reduced risk of Graft versus Host disease post-transplant. Our program offers a holistic approach to transplant with our cancer support services including nutrition, psychological, social work, rehabilitation, and survivorship. Miami Cancer Institute began performing allogeneic transplants in July 2019 and became a member of the NMDP/Be the Match network in June 2020.This center has been performing allogeneic transplants since 2019 and has been an NMDP transplant center since June 2020.
Attending physicians
Adult - Nadia Bambace, Lyle Feinstein, Guenther Koehne, Yuliya Linhares, George Nahas, Ariel Perez Perez, Marco RuizTransplants performed
Marrow/PBSC onlyCord blood transplants
Adult onlyOther programs and services
This institute offers CAR T Cell Therapy as well as Bloodless Autologous Stem Cell Transplants.
The Institute offers an impressive roster of established community oncologists and renowned experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. Selected, as Florida’s only member of the Memorial Sloan Kettering Cancer Alliance, Miami Cancer Institute is part of a meaningful clinical collaboration that affords patients in South Florida access to innovative treatments and ensures that the standards of care developed by their multidisciplinary disease management teams match those at Memorial Sloan Kettering Cancer Institute.Patient survival information for this center
This center's actual 1-year survival results are similar to the expected rate for this center*.The survival information we have for this center includes ONLY:- Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2020, 2021, 2022 and
- Who had their transplant at a U.S. transplant center, and
- Who had follow-up information provided by the transplant center for analysis
For this center, we have survival information for 62 patients.The actual 1-year survival of these patients is 74.2%.Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 57.7% and 79.6%.For help with understanding these statistics, please see Understanding Transplant Outcomes.For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report (Opens in a new tab) at bloodcell.transplant.hrsa.gov.* The expected survival rate for a transplant center can be below, similar to, or above the range listed. This is based on comparing patient survival at all centers that treated patients with similar diseases.
The survival rate cannot tell how you will do with your transplant. Talk to your doctor to understand your prognosis or the likely course of your disease.
Total adult transplants
126
Transplants reported by the centers (from January 1, 2022 to December 31, 2023)
Marrow PBSC Cord blood Total AllogeneicRelated donorMarrow0PBSC18Cord blood0Total18Unrelated donorMarrow0PBSC32Cord blood0Total32Total allogeneicMarrow0PBSC50Cord blood0Total50AutologousMarrowBoth marrow & PBSC 76PBSC—Cord blood—Total76Total combinedMarrowBoth marrow & PBSC 126PBSC—Cord blood0Total126All Diseases
Number of transplants by age reported from January 1, 2022 to December 31st, 2023(includes marrow, PBSC and cord blood)
0-18 19-44 45-64 65+ Total Related 0-18019-44545-64765+6Total18Unrelated 0-18019-44645-641565+11Total32Autologous 0-18019-44745-643765+32Total76Total 0-18019-441845-645965+49Total126Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.
Centers are not required to report autologous transplants so the numbers might be incomplete.
More information about transplants can be found:
- U.S. Transplant Data by Center (Opens in a new tab) report at blood cell.transplant.hrsa.gov
- List of diseases
Transplant center resources
Transplant center coordinatorLisandra Rodriguez PerezPhone: 786-527-8489If you have questions about costs and financial services at this center, please call the transplant center’s direct phone number.NMDP patient navigators
Patient navigators can answer your questions about choosing a transplant center and provide support and education to help you throughout your transplant journey.
- Inside the United States: 1 (888) 999-6743
- Outside the United States: 1 (763) 406-3410. (Long distance or international charges may apply.)
Email: patientinfo@nmdp.org
More resources
- Choosing a transplant center
- Preparing for transplant
- Learn about transplant outcomes and treatment decisions (Opens in a new tab)
- Support and resources (including non-English materials)
- U.S. Transplant Data by Center (Opens in a new tab) at blood cell.transplant.hrsa.gov
No survivorship program information is available. Contact the center for information about post-transplant care.